Sign in
The role of MYD88-dependent receptors in the anti-tumor efficacy of the EGFR inhibitor Erlotinib in head and neck cancer
Thesis   Open access

The role of MYD88-dependent receptors in the anti-tumor efficacy of the EGFR inhibitor Erlotinib in head and neck cancer

Adam Taylor Koch
University of Iowa
Master of Science (MS), University of Iowa
Summer 2014
DOI: 10.17077/etd.huzxr92x
pdf
The role of MYD88-dependent receptors in the anti-tumor efficacy6.35 MBDownloadView

Abstract

Pathology EGFR erlotinib IL-1 alpha IL-1 Receptor MyD88 TLR5

Details

Metrics

396 File views/ downloads
97 Record Views